Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
The American Journal of Medicine|June 6, 2016
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart FailureKumar Sanam, Vikas Bhatia, Navkaranbir S Bajaj, et al.
The American Journal of Cardiology|November 29, 2011
Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillationBrita Roy, Ravi V Desai, Marjan Mujib, et al.
The American Journal of Medicine|July 13, 2016
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart FailureCherinne Arundel, Phillip H Lam, Rahul Khosla, et al.
International Journal of Cardiology|November 22, 2016
Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactonePhillip H Lam, Daniel J Dooley, Chakradhari Inampudi, et al.
The American Journal of Medicine|March 16, 2013
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failureRobert C Bourge, Jerome L Fleg, Gregg C Fonarow, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 13, 2016
Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptorsJoAnn Lindenfeld, Joseph C Cleveland, David P Kao, et al.
Heart Rhythm O2|March 4, 2022
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trialWilliam T Abraham, Jonathan P Piccini, Christopher Dufton, et al.
Pageof 18